Global /Germany /Healthcare /Drug Manufacturers - General /BAYN
chevron_leftBack

Bayer Aktiengesellschaft

BAYN
XETRA: BAYN Delayed
22.11EUR 2.9%
25.05 USD
As of 24 April 2025, Bayer Aktiengesellschaft has a market cap of $24.61B USD, ranking #813 globally and #32 in Germany. It ranks #70 in the Healthcare sector, and #19 in the Drug Manufacturers - General industry.
Global Rank
813
Country Rank
32
Sector Rank
70
Industry Rank
19
Key Stats
Market Cap
$24.61BUSD
21.72B EUR
Enterprise Value
$61.85BUSD
54.58B EUR
Revenue (TTM)
$52.82BUSD
46.61B EUR
EBITDA (TTM)
$10.36BUSD
9.14B EUR
Net Income (TTM)
-$2.89BUSD
-2.55B EUR
EBITDA Margin
20%
Profit Margin
-5.5%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
William Anderson open_in_new
Employees
90,587
Founded
1863
Website
bayer.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
2.9% 5.5% -8.2% 5.3% -15% -19%
Upcoming Earnings
Earnings Date
Tue, May 13

Markets

Exchange Ticker Price
Deutsche Börse Xetra
MIC: XETR
PRIMARY
BAYN
Bayer AG
ISIN: DE000BAY0017
Shares Out.:
982.424M1 Shares Float: 982.424M2
TV:
SA:
YF:
GF:
BA:
MS:
22.11 EUR
London Stock Exchange
MIC: XLON
0P6S
Bayer AG
ISIN: DE000BAY0017
TV:
SA:
YF:
GF:
BA:
MS:
21.60 EUR
Borsa Italiana
MIC: XMIL
1BAYN
Bayer AG
ISIN: DE000BAY0017
Shares Out.:
982.424M1 Shares Float: 982.424M2
TV:
SA:
YF:
GF:
BA:
MS:
21.89 EUR
Frankfurt Stock Exchange
MIC: XFRA
BAYN
Bayer AG
ISIN: DE000BAY0017
TV:
SA:
YF:
GF:
BA:
MS:
22.11 EUR
Mexican Bolsa
MIC: XMEX
BAYN (BAYN/N)
Bayer AG
ISIN: DE000BAY0017
Shares Out.:
982.424M1 Shares Float: 982.424M2
TV:
SA:
YF:
GF:
BA:
MS:
492.21 MXN
OTC Markets
MIC: OTCM
BAYRY
Bayer AG ADR
ISIN: US0727303028
Shares Out.:
3.93B1 Shares Float: 3.93B2
TV:
SA:
YF:
GF:
BA:
MS:
6.27 USD
OTC Markets
MIC: OTCM
BAYZF
Bayer AG
ISIN: DE000BAY0017
Shares Out.:
982.424M1 Shares Float: 982.424M2
TV:
SA:
YF:
GF:
BA:
MS:
24.68 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, pain and cardiovascular risk prevention products, digestive health products, allergy products, and cold and cough products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Similar Companies

Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
Eli Lilly and Co.
LLY
$744.81B
3K%
Johnson & Johnson
JNJ
$374.44B
1K%
AbbVie Inc.
ABBV
$313.2B
1K%
Novo Nordisk A/S
NOVO-B
$276.68B
1.82T DKK
1K%
Roche Holding AG
RO
$246.36B
204.44B CHF
901%